Cytogen Inc (217330) - Total Liabilities

Latest as of December 2025: ₩26.25 Billion KRW ≈ $17.79 Million USD

Based on the latest financial reports, Cytogen Inc (217330) has total liabilities worth ₩26.25 Billion KRW (≈ $17.79 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Cytogen Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.

Cytogen Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Cytogen Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Cytogen Inc's balance sheet.

Cytogen Inc Competitors by Total Liabilities

The table below lists competitors of Cytogen Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Royalindo Investa Wijaya JK:INDO	Indonesia	Rp6.47 Billion
Turism Felix B RO:TUFE	Romania	RON65.86 Million
TOPMATERIAL LTD KQ:360070	Korea	₩81.53 Billion
Toba Pulp Lestari Tbk JK:INRU	Indonesia	Rp6.65 Trillion
SMCore.Inc KQ:007820	Korea	₩54.09 Billion
Carnival Industrial Corp TW:1417	Taiwan	NT$468.63 Million
Nh Prime Reit Co Ltd KO:338100	Korea	₩2.03 Billion
MINDs Lab Inc. KQ:377480	Korea	₩30.32 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Cytogen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Cytogen Inc balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.74	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.42	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cytogen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cytogen Inc (2014–2025)

The table below shows the annual total liabilities of Cytogen Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩26.25 Billion ≈ $17.79 Million	+9.85%
2024-12-31	₩23.89 Billion ≈ $16.19 Million	+13.27%
2023-12-31	₩21.09 Billion ≈ $14.30 Million	-40.69%
2022-12-31	₩35.56 Billion ≈ $24.10 Million	+9.36%
2021-12-31	₩32.52 Billion ≈ $22.04 Million	+226.05%
2020-12-31	₩9.97 Billion ≈ $6.76 Million	+455.30%
2019-12-31	₩1.80 Billion ≈ $1.22 Million	+152.43%
2018-12-31	₩711.51 Million ≈ $482.18K	-24.91%
2017-12-31	₩947.50 Million ≈ $642.11K	-79.34%
2016-12-31	₩4.59 Billion ≈ $3.11 Million	+187.30%
2015-12-31	₩1.60 Billion ≈ $1.08 Million	+1.68%
2014-12-31	₩1.57 Billion ≈ $1.06 Million	--

About Cytogen Inc

KQ:217330 Korea Diagnostics & Research

Market Cap

$48.00 Million

₩70.82 Billion KRW

Market Cap Rank

#22149 Global

#1380 in Korea

Share Price

₩3070.00

Change (1 day)

+0.33%

52-Week Range

₩2320.00 - ₩9420.00

All Time High

₩22599.98